Onderneming ShanXi C&Y Pharmaceutical Group Co.,LTD.
Aandelen
300254
CNE1000016D0
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,27 CNY | +2,99% | -10,11% | -14,12% |
Vakgebied
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Anti-infective Drugs
22,2
%
| 173 | 20,9 % | 177 | 22,2 % | +2,23% |
Urinary System Drugs
20,7
%
| 129 | 15,5 % | 165 | 20,7 % | +28,39% |
Other Medicines
17,0
%
| 119 | 14,4 % | 136 | 17,0 % | +13,61% |
Pediatric Use
8,4
%
| 70 | 8,4 % | 67 | 8,4 % | -3,42% |
Anti-allergy
8,3
%
| 166 | 20,1 % | 66 | 8,3 % | -60,22% |
Respiratory Medicine
7,2
%
| 39 | 4,7 % | 58 | 7,2 % | +47,77% |
Pharmaceutical Raw Materials and Intermediates
7,1
%
| 46 | 5,6 % | 57 | 7,1 % | +22,82% |
Service
3,3
%
| 34 | 4,1 % | 27 | 3,3 % | -20,84% |
Kidney Medicine
3,3
%
| 37 | 4,5 % | 26 | 3,3 % | -29,20% |
Health Food
1,6
%
| 11 | 1,3 % | 13 | 1,6 % | +16,91% |
Other Business
0,9
%
| 4 | 0,5 % | 7 | 0,9 % | +65,81% |
Commercial
0,1
%
| 0 | 0,1 % | 1 | 0,1 % | +71,18% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 807 | 97,3 % | 799 | 100,0 % | -0,93% |
Hong Kong
0,0
%
| 22 | 2,7 % | 0 | 0,0 % | -99,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Qun Zhao
CEO | Chief Executive Officer | 53 | 01-03-05 |
Yan Jie He
DFI | Director of Finance/CFO | 42 | 01-12-10 |
Hai Rong Zhong
BRD | Director/Board Member | 65 | 17-03-15 |
Jun Xian Yu
BRD | Director/Board Member | 57 | 01-03-05 |
Xu Hong Zhang
BRD | Director/Board Member | 53 | 01-03-05 |
Yuan Yuan Xue
IRC | Investor Relations Contact | - | - |
Ying Min Yu
PRN | Corporate Officer/Principal | 61 | 07-07-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qun Zhao
CEO | Chief Executive Officer | 53 | 01-03-05 |
Xu Hong Zhang
BRD | Director/Board Member | 53 | 01-03-05 |
Jun Xian Yu
BRD | Director/Board Member | 57 | 01-03-05 |
Hai Rong Zhong
BRD | Director/Board Member | 65 | 17-03-15 |
Hao Gao
BRD | Director/Board Member | 54 | 11-02-20 |
Le Qun Huang
CHM | Chairman | 69 | 01-02-20 |
Tao Ju
BRD | Director/Board Member | 38 | 11-02-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 241 618 563 | 182 672 525 ( 75,60 %) | 0 | 75,60 % |
Bedrijfsgegevens
Shanxi C&Y Pharmaceutical Group Co., Ltd.
1378, Heng'an Street Economic & Technological Dev Zone
037010, Datong
+
http://www.cy-pharm.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,12% | 276 mln. | |
+45,82% | 765 mld. | |
-6,16% | 354 mld. | |
+19,86% | 331 mld. | |
+9,32% | 299 mld. | |
+18,87% | 248 mld. | |
-1,72% | 219 mld. | |
+11,21% | 216 mld. | |
+5,90% | 164 mld. | |
-0,73% | 162 mld. |
- Beurs
- Aandelen
- Koers 300254
- Onderneming ShanXi C&Y Pharmaceutical Group Co.,LTD.